Do not miss our special. Click here

Glass Industry News

Gerresheimer increases third-quarter revenues

, Gerresheimer AG
  •  Revenues up 2.2% to EUR 323.9m (+3.2% at constant exchange rates)
  •  Adjusted EBITDA with slight improvement on prior-year quarter at EUR 62.1m
  •  Net income slightly over prior-year level at EUR 19.8m
  •  Adjusted earnings per share exactly match prior-year quarter, at EUR 0.67
  •  Outlook for financial year 2014 made more specific

Gerresheimer AG again increased revenues in the third quarter of financial year 2014. “Our products continue to enjoy high demand. We saw solid growth in the third quarter, although growth was a little bit slower than previously expected. For this reason, we are making our outlook for 2014 more specific. We will continue to invest in growth projects and expand our production capacities worldwide,” said Uwe Röhrhoff, Chief Executive Officer of Gerresheimer AG. As one of the leading partners to the pharma and healthcare industry worldwide, Gerresheimer AG develops and produces glass and plastic packaging for drugs and cosmetics along with complex drug delivery products such as insulin pens, asthma inhalers and prefillable syringes.

Gerresheimer again increased revenues in the third quarter of financial year 2014 (December 1, 2013 to November 30, 2014). Revenues came to EUR 323.9m, representing growth of 2.2%. At constant exchange rates, revenues grew by 3.2% compared with the prior-year quarter. The main driver of revenue growth was the pharmaceutical plastic packaging business as well as the engineering and tooling business, which typically precedes mass production of medical plastic systems such as insulin pens and asthma inhalers. Revenues in the prefillable syringe system business increased slightly, as did laboratory glassware revenues. Glass primary packaging took a revenue hit, primarily due to destocking by some of the US pharmaceuticals customers. In addition, less pharma-ceutical glass was delivered in the US in the third quarter given that regulatory requirements forced some pharmaceutical companies to endure production halts.

Gerresheimer improved adjusted EBITDA slightly, from EUR 61.6m in the prior-year quarter to EUR 62.1m in the third quarter of 2014. The adjusted EBITDA margin was 19.2% in the third quarter, slightly below the 19.4% margin in the comparative period. Net income for the third quarter totaled EUR 19.8m, slightly higher than the figure of EUR 19.5m for the same period of the prior year. Adjusted earnings per share were EUR 0.67 in the third quarter, as in the prior-year quarter.

The Gerresheimer Group’s capital expenditure in the third quarter of 2014 came to EUR 22.4m. Capital expenditure continued to focus on adding production capacity for medical plastic systems such as insulin pens and inhalers in Horsovsky Tyn, Czech Republic, and Peachtree City, USA.

, Gerresheimer AG

Les informations publiées sur notre portail sont soumises au droit d´auteur et appartiennent à la société en question resp. à la source des nouvelles. Tous les droits sont réservés expressément. N´importe quel utilisateur qui accède à un tel matériel peut faire ainsi seulement pour sa propre utilisation personnelle, et l´usage d´un tel matériel est au risque unique de l´utilisateur. La redistribution ou toute autre exploitation commerciale d´un tel matériel de nouvelles est expressément interdite. Là où un tel matériel de nouvelles est fourni par un tiers, chaque utilisateur accepte d´observer et être lié par les limites spécifiques de l´utilisation s´appliquant à un tel matériel de nouvelles. Glass Global ne représente ou n´approuve pas l´exactitude ou la fiabilité d´aucune des informations citées dans les nouvelles ou pages externes auxquelles on se réfère ici.

Should the content or the design of these sites violate third parties rights or legal prescriptions, we kindly ask you to send us a respective message without invoice or cost. We guarantee that passages where the claim is considered as justified will be removed immediately, without any necessity to involve any lawyer into this issue. We will reject any claim caused by submission of a honorary note in this regard without any prior contact and confirmation of the issueby us and we reserve the right ssue counter claim ourselves because of violation of aforesaid conditions.

Info Grid

Glass studies

Updated worldwide glass study 2020

Updated hollow glass study 2020

Request more information

Updated float glass study 2020

Request more information

Portrait de la société

Updated worldwide glass market study 2020 available now for flat, container glass and tableware

We have updated our international studies on flat glass, container glass and tableware for 2020.

This unique software provides a global overview about glass producers and technical details. Easy to use and clear tables summarize information and data about glass makers such as: Glass types: flat glass, container glass, tableware, production capacities in regions and countries, number of furnaces, furnace types, year of construction, glass types and sub-types, products, project information, special news and downloads.

Further databases supplying demoscopic data and import and export data complete the market survey. Based on these data, prepare individual country profiles with information about local production capacities, local market sizes and expected demand in the future.

Request your offer via

Updated Hollow glass study 2020


Updated Float glass study 2020